ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner
Published in Brain, 2025
This study demonstrates that the ApoE4 risk allele lowers the threshold of plasma phosphorylated tau 217 (ptau217) required to drive fibrillar tau aggregation and spread in Alzheimer’s disease in a dose-dependent manner.
Recommended citation: Steward, A., Dewenter, A., Hirsch, F., Roemer-Cassiano, S. N., Zhu, Z., Dehsarvi, A., Biel, D., Klonowski, M., Frontzkowski, L., Palleis, C., Gnörich, J., Dichgans, M., Höglinger, G., Brendel, M., & Franzmeier, N. (2025). ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner. Brain, awaf463. https://doi.org/10.1093/brain/awaf463
Download Paper